Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement (NCT06571747)
🩺 Plain-English Summary (8th-Grade Level)
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed. KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
Who can join: Review the eligibility criteria below.
Location: Kaiser Permanente Northern California — Pleasanton, California
Age range: 18 Years
🧪 Interventions in This Study
- Cardiovascular-Focused Nudge Communication (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Kaiser Permanente Northern California — Pleasanton, California
- Kaiser Permanente Mid Atlantic States — Bethesda, Maryland
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiovascular Diseases
- The Jackson Heart Study of Cardiovascular Disease Among African Americans — Jackson, Mississippi
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials — Toronto, Ontario
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study — Ottawa, Ontario
- Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption — Davis, California
- Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring — Arlington, Texas
- Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) — Baltimore, Maryland
Explore by condition: All Cardiovascular Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.